Ramipril Capsule
Product Images NDC 68001-430

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ramipril (NDC 68001-430). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 01

A data table titled 'Summary of Combined Components and Endpoints—HOPE Study' comparing outcomes between placebo (N=4652) and Ramipril (N=4645) groups. The table presents percentages for combined endpoints (myocardial infarction, stroke, or cardiovascular death), individual component endpoints, and overall mortality, alongside relative risk values with 95% confidence intervals and p-values.*

FDA Label Image

Image 02

A Kaplan-Meier survival estimate graph comparing the composite outcome of myocardial infarction, stroke, or death from cardiovascular causes between Ramipril and placebo groups. The x-axis represents days of follow-up, and the y-axis indicates the proportion of patients experiencing outcomes. Ramipril group shows a lower proportion over time compared to placebo, with a p-value of 0.0001 indicating statistical significance.*

FDA Label Image

Image 03

A data table titled 'Summary of Combined Endpoints and Components in Diabetics—HOPE Study' comparing placebo and Ramipril groups in cardiovascular outcomes. It lists incidence and relative risk of myocardial infarction, stroke, and death from cardiovascular causes. Also includes a figure showing the effect of Ramipril on composite outcomes by patient subgroups such as cardiovascular disease status, diabetes, age, sex, hypertension, and others, displaying relative risk with confidence intervals.*

FDA Label Image

Image 04

A data table titled 'Reasons for Discontinuation or Temporary Interruption of Treatment—HOPE Study' comparing percentages of discontinuation and reasons for stopping between Placebo (N=4652) and Ramipril (N=4645). It shows overall discontinuation rates, permanent discontinuation, and specific reasons like cough, hypotension or dizziness, and angioedema.*

FDA Label Image

Ramipril Capsules 1.25mg 100 Capsules Rev 01/2020 (Ramipril Fig1)

The label for Ramipril Capsules, USP 1.25 mg oral dosage form by BluePoint Laboratories. The packaging indicates 100 capsules per container with NDC 68001-428-00 and includes storage instructions and manufacturer information for Aurobindo Pharma Limited, Hyderabad, India. The label also contains warnings, pharmacist dispensing notes, and dosage guidance references.*

FDA Label Image

Ramipril Capsules Usp 2.5mg 100 Capsules Rev 01/2020 (Ramipril Fig3)

Ramipril Capsules USP 2.5 mg oral capsules by BluePoint Laboratories. The label indicates 100 capsules per container and includes dosing and storage information. Manufactured by Aurobindo Pharma Limited for BluePoint Laboratories, with an NDC of 68001-429-00. The label also features warnings and pharmacist dispensing instructions.*

FDA Label Image

Ramipril Capsules Usp 5mg 100 Capsules Rev 01/2020 (Ramipril Fig5)

Ramipril Capsules USP 5 mg oral capsules packaging label shows 100 capsules by BluePoint Laboratories. The label includes dosage strength 5 mg, NDC 68001-430-00, manufacturer information for Aurobindo Pharma Limited in Hyderabad, India, and storage instructions at 20° to 25°C. It contains warnings, pharmacist dispensing advice, and a barcode.*

FDA Label Image

Ramipril Capsules Usp 10mg 100 Capsules Rev 01/2020 (Ramipril Fig7)

Ramipril Capsules, USP 10 mg oral capsules label showing the product name, strength, and quantity of 100 capsules. Manufactured for BluePoint Laboratories by Aurobindo Pharma Limited, with usage warnings, storage instructions, and dispensing information. The label includes the NDC code 68001-431-00 and a barcode.*

FDA Label Image

Chemical Structure (Ramipril Str)

Chemical structure of Ramipril, showing its molecular arrangement including rings, functional groups, and bonds as a white-on-black line diagram.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.